Furthermore, similar results were observed in the other CCDC137-overexpressing HCCLM3 cells, verifying that AKT signaling is the major downstream target of CCDC137 in HCC (Fig. 4h-j). The gene discussed is AKT1; the disease is hepatocellular carcinoma.